Therapeutic targets : modulation, inhibition, and activation
Author(s)
Bibliographic Information
Therapeutic targets : modulation, inhibition, and activation
John Wiley & Sons, c2012
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
The Latest Applications For Cellmechanism Research in Drug Discovery
Designed to connect research on cell mechanisms with the drug discovery process, Therapeutic Targets: Modulation, Inhibition, and Activation introduces readers to a range of new concepts and novel approaches to drug screening and therapeutic drug targeting to help inform future avenues of drug research. Highly topical, this accessible edited volume features chapters contributed by respected experts from around the globe.
The book helps postgraduate students and professional scientists working in academia and industry understand the molecular mechanisms of pharmacology, current pharmacological knowledge, and future perspectives in drug discovery, focusing on important biochemical protein targets and drug targeting strategies for specific diseases. Examining the pharmacology of therapeutically undefined targets and their potential applications, it includes chapters on traditional therapeutic targets, including enzymes (phosphodiesterases and proteases), ion channels, and G protein-coupled receptors, as well as more recently identified avenues of exploration, such as lipids, nuclear receptors, gene promoters, and more.
Since different diseases require different targeting techniques, the book also includes dedicated chapters on strategies for investigating Alzheimer's, diabetes, pain, and inflammation treatments. Concluding with a cross-sectional look at new approaches in drug screening, Therapeutic Targets is an invaluable resource for understanding where the next generation of drugs are likely to emerge.
Table of Contents
Preface vii
Contributors ix
1. cAMP-Specific Phosphodiesterases: Modulation, Inhibition, and Activation 1
R. T. Cameron and George S. Baillie
2. Protease-Activated Receptor 2 37
Qihai Gu and Lu-Yuan Lee
3. Voltage-Gated Sodium Channels as Therapeutic Targets 63
Joshua S. Wingerd, Irina Vetter, and Richard J. Lewis
4. Multitarget Drugs for Stabilization of Calcium Cycling and Neuroprotection in Neurodegenerative Diseases and Stroke 123
Antonio M. G. de Diego, Silvia Lorrio, Jesus M. Hernandez-Guijo, Luis Gandia, and Antonio G. Garcia
5. Oligomerization of G-Protein-Coupled Receptors 201
Juan F. Lopez-Gimenez and Javier Gonzalez-Maeso
6. Sigma 1 Receptor Chaperone: Pharmacology and Therapeutic Perspectives 225
Daniel Zamanillo, Enrique Portillo-Salido, Jose Miguel Vela, and Luz Romero
7. Lipids as New Targets 279
Eduardo Domunguez
8. Knowledge Base for Nuclear Receptor Drug Discovery 309
Albert A. Antolin and Jordi Mestres
9. Gene Promoters and Transcription Control Regions as Therapeutic Targets 327
Antonio Zorzano, David Sebastian, Jana Sanchez-Wandelmer, Laia Miret, and Fernando Albericio
10. Roles of Glucagon-Like Peptide and Glucose-Dependent Insolinotropic Polypeptide Hormones in Brain Function and Neurodegeneration 351
Christian Hoelscher
11. Exocytotic Machinery as a Target for the Development of New Drugs for Schizophrenia 375
Maria Jose Guerrero, Itsaso Hormaeche, Maria Uribarri, Julie Masse, and Jose Maria Palacios
12. Targeting Epigenetic Abnormalities in the Brain 409
Erin Y. Sterner, Lisa E. Kalynchuk, and Hector J. Caruncho
13. Rodent Models as Tools for Discovering Novel Therapeutic Targets in the Brain: The Case of Epilepsy 427
Justin J. Botterill, Axel J. Guskjolen, Lisa E. Kalynchuk, and Hector J. Caruncho
14. New Approaches Applied to Drug Screening 455
Jose Brea and Maria Isabel Loza
Index 477
by "Nielsen BookData"